Risk factors for persistent and new chronic opioid use in patients undergoing total hip arthroplasty: A retrospective cohort study

BMJ Open

Volumn 6, Issue 4, 2016, Pages

  Inacio, Maria C S ^a   Hansen, Craig ^a   Pratt, Nicole L ^a   Graves, Stephen E ^b   Roughead, Elizabeth E ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HYPNOTIC AGENT; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; SEDATIVE AGENT; NARCOTIC ANALGESIC AGENT;

AGED; ARTICLE; BACKACHE; BIBLIOGRAPHIC DATABASE; COHORT ANALYSIS; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DRUG EXPOSURE; DRUG USE; ELECTIVE SURGERY; FEMALE; GOVERNMENT; HUMAN; HYPERLIPIDEMIA; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY; RISK FACTOR; STOMACH ACID; TOTAL HIP PROSTHESIS; WEIGHT REDUCTION; ADVERSE EFFECTS; AUSTRALIA; COMPLICATION; HIP REPLACEMENT; OPIOID-RELATED DISORDERS; PAIN; TREATMENT OUTCOME; VERY ELDERLY; VETERAN;

AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; ARTHROPLASTY, REPLACEMENT, HIP; AUSTRALIA; FEMALE; HUMANS; MALE; OPIOID-RELATED DISORDERS; PAIN; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; VETERANS;

EID: 84971281630     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-010664     Document Type: Article

References (44)

1. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16:137-62.
2. Healthcare Cost and Utilization Project (HCUP). Nationwide inpatient sample (NIS). Statistical Brief 186. Secondary Healthcare Cost and Utilization Project (HCUP). Nationwide inpatient sample (NIS). Statistical Brief 186. 2014. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb186-Operating-Room-Procedures-United-States-2012.pdf.
3. Australian Institute of Health and Welfare (AIHW). Admitted patient care 2013-14: Australian hospital statistics. Secondary Australian Institute of Health and Welfare (AIHW). Admitted patient care 2013- 14: Australian hospital statistics. 2014. http://www.aihw.gov.au/publication-detail/?id=60129550483.
4. Beswick AD, Wylde V, Gooberman-Hill R, et al. What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients. BMJ Open 2012;2:e000435.
5. Rajamäki TJ, Jämsen E, Puolakka PA, et al. Diabetes is associated with persistent pain after hip and knee replacement. Acta Orthop 2015;86:586-93.
6. Singh JA, Lewallen D. Predictors of pain and use of pain medications following primary total hip arthroplasty (THA): 5, 707 THAs at 2-years and 3, 289 THAs at 5-years. BMC Musculoskelet Disord 2010;11:90.
7. Valdes AM, Warner SC, Harvey HL, et al. Use of prescription analgesic medication and pain catastrophizing after total joint replacement surgery. Semin Arthritis Rheum 2015;45:150-5.
8. Hastie BA, Gilson AM, Maurer MA, et al. An examination of global and regional opioid consumption trends 1980-2011. J Pain Palliat Care Pharmacother 2014;28:259-75.
9. Morden NE, Munson JC, Colla CH, et al. Prescription opioid use among disabled Medicare beneficiaries: intensity, trends, and regional variation. Med Care 2014;52:852-9.
10. Frenk SM, Porter KS, Paulozzi LJ. Prescription opioid analgesic use among adults: United States, 1999-2012. NCHS Data Brief 2015;189:1-8.
11. Roxburgh A, Bruno R, Larance B, et al. Prescription of opioid analgesics and related harms in Australia. Med J Aust 2011;195:280-4.
12. Larochelle MR, Zhang F, Ross-Degnan D, et al. Trends in opioid prescribing and co-prescribing of sedative hypnotics for acute and chronic musculoskeletal pain: 2001-2010. Pharmacoepidemiol Drug Saf 2015;24:885-92.
13. Levy B, Paulozzi L, Mack KA, et al. Trends in opioid analgesic-prescribing rates by specialty, U.S., 2007-2012. Am J Prev Med 2015;49:409-13.
14. Kehlet H, Dahl JB. Anaesthesia, surgery, and challenges in postoperative recovery. Lancet 2003;362:1921-8.
15. DuPen A, Shen D, Ersek M. Mechanisms of opioid-induced tolerance and hyperalgesia. Pain Manag Nurs 2007;8:113-21.
16. Benyamin R, Trescot AM, Datta S, et al. Opioid complications and side effects. Pain Physician 2008;11(Suppl):S105-20.
17. Caughey GE, Vitry AI, Gilbert AL, et al. Prevalence of comorbidity of chronic diseases in Australia. BMC Public Health 2008;8:221.
18. Cram P, Lu X, Kaboli PJ, et al. Clinical characteristics and outcomes of Medicare patients undergoing total hip arthroplasty, 1991-2008. JAMA 2011;305:1560-7.
19. Vogeli C, Shields AE, Lee TA, et al. Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs. J Gen Intern Med 2007;22(Suppl 3):391-5.
20. Lanting BA, MacDonald SJ. The painful total hip replacement: diagnosis and deliverance. Bone Joint J 2013;95B(Suppl A):70-3.
21. WHO. Collaborating centre for drug statistics methodology, guidelines for ATC classification and DDD assignment. 2014. Oslo, Norway, 2013. http://www.whocc.no/filearchive/publications/1-2013guidelines.pdf.
22. Health AGDo. Australian Goverment Department of Health. Pharmaceutical Benefits Services. Secondary Australian Goverment Department of Health. Pharmaceutical Benefits Services. 2014. http://www.pbs.gov.au/browse/medicine-listing.
23. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM). Secondary International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM) July 2013. 2013. https://www.accd.net.au/Icd10.aspx.
24. Von Korff M, Saunders K, Thomas Ray G, et al. De facto long-term opioid therapy for noncancer pain. Clin J Pain 2008;24:521-7.
25. Australian and New Zealand College of Anaesthetist FoPM. Opioid Conversion to oral Morphine Equivalent Daily Dose (oMEDD). Secondary Opioid Conversion to oral Morphine Equivalent Daily Dose (oMEDD). 2014. http://www.fpm.anzca.edu.au/resources/professional-documents/OPIOID20DOSE20EQUIVALENCE.pdf.
26. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-9.
27. Fishman PA, Goodman MJ, Hornbrook MC, et al. Risk adjustment using automated ambulatory pharmacy data: The RxRisk model. Med Care 2003;41:84-99.
28. Votrubec M, Thong I. Neuropathic pain-a management update. Aust Fam Physician 2013;42:92-7.
29. Pandeya N, Green AC, Whiteman DC, et al. Prevalence and determinants of frequent gastroesophageal reflux symptoms in the Australian community. Dis Esophagus 2012;25:573-83.
30. Ruszniewski P, Soufflet C, Bartheeéleeémy P. Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: An observational study. Aliment Pharmacol Ther 2008;28:1134-9.
31. Liu SS, Buvanendran A, Rathmell JP, et al. Predictors for moderate to severe acute postoperative pain after total hip and knee replacement. Int Orthop 2012;36:2261-7.
32. Nikolajsen L, Brandsborg B, Lucht U, et al. Chronic pain following total hip arthroplasty: A nationwide questionnaire study. Acta Anaesthesiol Scand 2006;50:495-500.
33. Clarke H, Soneji N, Ko DT, et al. Rates and risk factors for prolonged opioid use after major surgery: population based cohort study. BMJ 2014;348:g1251.
34. Petre BM, Roxbury CR, McCallum JR, et al. Pain reporting, opiate dosing, and the adverse effects of opiates after hip or knee replacement in patients 60 years old or older. Geriatr Orthop Surg Rehabil 2012;3:3-7.
35. Deyo RA, Von Korff M, Duhrkoop D. Opioids for low back pain. BMJ 2015;350:g6380.
36. Sehgal N, Manchikanti L, Smith HS. Prescription opioid abuse in chronic pain: A review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician 2012;15(Suppl):ES67-E92.
37. Wylde V, Jeffery A, Dieppe P, et al. The assessment of persistent pain after joint replacement. Osteoarthritis Cartilage 2012;20:102-5.
38. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55:754-62.
39. Rogal SS, Winger D, Bielefeldt K, et al. Pain and opioid use in chronic liver disease. Dig Dis Sci 2013;58:2976-85.
40. Jensen-Dahm C, Gasse C, Astrup A, et al. Frequent use of opioids in patients with dementia and nursing home residents: A study of the entire elderly population of Denmark. Alzheimers Dement 2015;11:691-9.
41. Yu EW, Bauer SR, Bain PA, et al. Proton pump inhibitors and risk of fractures: A meta-analysis of 11 international studies. Am J Med 2011;124:519-26.
42. Sadoghi P, Liebensteiner M, Agreiter M, et al. Revision surgery after total joint arthroplasty: A complication-based analysis using worldwide arthroplasty registers. J Arthroplasty 2013;28:1329-32.
43. Edlund MJ, Steffick D, Hudson T, et al. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain 2007;129:355-62.
44. Breivik H, Borchgrevink PC, Allen SM, et al. Assessment of pain. Br J Anaesth 2008;101:17-24.